Association of BCSC-1 with human esophageal squamous cell carcinoma

Neoplasma

Volumn 62, Issue 5, 2015, Pages 765-769

  Zhao, C L ^a   Yu, W J ^a   Gao, Z Q ^a   Li, W T ^a   Gao, W ^a   Yang, W W ^a   Feng, W G ^a   Ju, J Y ^a  

^a WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

BCSC 1; ESCC; Immunohistochemistry

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BREAST CANCER SUPPRESSOR CANDIDATE 1; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA ISOLATION; TUMOR INVASION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

EID: 84943631732     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2015_091     Document Type: Article

References (25)

1. JAMAL A, BRAY F, CENTER MM, FERLAY J, WARD E, FORMAN D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90. doi: 10.3322/caac.20107 http://dx.doi.org/10.3322/caac.20107
2. STONER GD, GUPTA A. Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 2001; 22: 1737–1746. doi: 10.1093/carcin/22.11.1737 http://dx.doi.org/10.1093/carcin/22.11.1737
3. Paccez JD, Duncan K, Vava A, Correa RG, Libermann TA et al. Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in Oesophageal Squamous Cell Carcinoma. Mol Biol Cell 2015 Jan 7. pii: mbc.E14–04-0868. Epub ahead of print
4. WANG Q, LU J, YANG C, WANG X, CHENG L et al. CASK and its target gene Reelin were co-upregulated in human esophageal carcinoma. Cancer Lett 2002; 179: 71–77. doi: 10.1016/S0304–3835(01)00846–1 http://dx.doi.org/10.1016/S0304-3835(01)00846-1
5. ZHANG Y, FENG YB, SHEN XM, CHEN BS, DU XL et al. Exogenous expression of Esophagin/SPRR3 attenuates the tumorigenicity of esophageal squamous cell carcinoma cells via promoting apoptosis. Int J Cancer 2008; 122: 260-266. doi: 10.1002/ijc.23104 http://dx.doi.org/10.1002/ijc.23104
6. Martin ES, Cesari R, Pentimalli F, Yoder K, Fishel R et al. The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene. Proc Natl Acad Sci U S A 2003; 100: 11517-11522. doi: 10.1073/pnas.1934602100 http://dx.doi.org/10.1073/pnas.1934602100
7. RASIO D, NEGRINI M, MANENTI G, DRAGANI TA, CROCE CM. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions. Cancer research 1995; 55: 3988-3991.
8. ZHOU YQ, CHEN SL, JU JY, SHEN L, LIU Y et al. Tumor suppressor function of BCSC-1 in nasopharyngeal carcinoma. Cancer Sci 2009; 100: 1817-1822. doi: 10.1111/j.1349-7006.2009.01261.x http://dx.doi.org/10.1111/j.1349-7006.2009.01261.x
9. MAZUMDER, Indra D, MITRA S, SINGH RK, DUTTA S et al. Inactivation of CHEK1 and EI24 are associated with the development of invasive cervical carcinoma: Clinical and prognostic implications. Int J Cancer 2011; 129: 1859-1871. doi: 10.1002/ijc.25849 http://dx.doi.org/10.1002/iic.25849
10. ANGHEL SI, Correa-Rocha R, BUDINSKA E, Bo-Ligan KF et al. Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF. Pigment Cell Melanoma Res 2012; 25: 482-487. doi: 10.1111/j.1755-148X. 2012.01018.x
11. TONG T, ZHONG Y, KONG J, DONG L, SONG Y et al. Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma. Clin Cancer Res 2004; 10: 7304-7310. doi: 10.1158/ 1078- 0432. CCR-04-0806
12. ZHAO C, GONG L, LI W, CHEN L. Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2010; 136: 9-16. doi: 10.1007/s00432-009-0630-4 http://dx.doi.org/10.1007/s00432-009-0630-4
13. FENG YB, LIN DC, SHI ZZ, WANG XC, SHEN XM et al. Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma. Int J Cancer 2009; 124: 578-588. doi: 10.1002/ijc.23990 http://dx.doi.org/10.1002/ iic.23990
14. LIU YJ, MENG FT, WANG LL, ZHANG LF, CHENG XP, ZHOU JN. Apolipoprotein E influences melatonin biosynthesis by regulating NAT and MAOA expression in C6 cells. J Pineal Res 2012; 52: 397-402. doi: 10.1111/j.1600-079X.2011.00954.x http://dx.doi.org/10.1111/i.1600-079X.2011.00954.x
15. SEBASTIAN C. Tracking down the origin of cancer: metabolic reprogramming as a driver of stemness and tum-origenesis. Crit Rev Oncog 2014; 19: 363-382. doi: 10.1615/ CritRevOncog.2014011844 http://dx.doi.org/10.1615/Crit-RevQncog.2014011844
16. CHEN F. Alternative RNA Structure-Coupled Gene Regulations in Tumorigenesis. Int J Mol Sci 2014; 16: 452-475. doi: 10.3390/ijms16010452 http://dx.doi.org/10.3390/ iims16010452
17. MORIN A, LETOUZE E, Gimenez-Roqueplo AP, Favi-Er J. Oncometabolites-driven tumorigenesis: From genetics to targeted therapy. Int J Cancer 2014; 135: 2237-2248. doi: 10.1002/ijc.29080 http://dx.doi.org/10.1002/iic.29080
18. CERDA C, SANCHEZ C, CLIMENT B, VAZQUEZ A, IRADI A et al. Oxidative stress and DNA damage in obesity-related tumorigenesis. Adv Exp Med Biol 2014; 824: 5-17. doi: 10.1007/978-3-319-07320-0_2 http://dx.doi.org/10.1007/978-3-319-07320-02
19. GAO F, LIANG B, Reddy ST, Farias-Eisner R, SU X. Role of inflammation -associated microenvironment in tumorigenesis and metastasis. Curr Cancer Drug Targets 2014; 14: 30-45. doi: 10.2174/15680096113136660107 http://dx.doi.org/10.2174/15680096113136660107
20. SHACKELFORD DB. Unravelling the connection between metabolism and tumorigenesis through studies of the liver kinase B1 tumour suppressor. J Carcinog 2013; 12: 16. doi: 10.4103/1477-3163.116323 http://dx.doi.org/10.4103/1477-3163.116323
21. VOLODKO N, GORDON M, SALLA M, GHAZALEH HA, BAKSH S. RASSF tumor suppressor gene family: biological functions and regulation. FEBS Lett 2014; 588: 2671-2684. doi: 10.1016/j.febslet.2014.02.041 http://dx.doi.org/10.1016/_i. febslet.2014.02.041
22. LIONTOS M, PATERAS IS, EVANGELOU K, GORGOULIS VG. The tumor suppressor gene ARF as a sensor of oxidative stress. Curr Mol Med 2012; 12: 704-715. doi: 10.2174/ 156652412800792633
23. SOLOMON H, BROSH R, BUGANIM Y, ROTTER V. Inactivation of the p53 tumor suppressor gene and activation of the Ras oncogene: cooperative events in tumorigenesis. Discov Med 2010; 9: 448-454.
24. CARTER SL, NEGRINI M, BAFFA R, Gillum, D R, Rosenberg AL et al. Loss of heterozygosity at 11q22-q23 in breast cancer. Cancer Res 1994; 54: 6270-6274.
25. HERBST RA, GUTZMER R, MATIASK F, MOMMERT S, CASPER U et al. Identification of two distinct deletion targets at 11q23 in cutaneous malignant melanoma. Int J Cancer 1999; 80: 205-209. doi: 10.1002/(SICI)1097-0215 (19990118) 80: 2<205:: AID-IJC8> 3.0.CO; 2-J